LUMEMA

Details for Australian Trade Mark No. 1151076 (hide)

Owner Myriad Genetics, Inc.

Convention US 27 April 2006 78871267

IR Number 904922

Filing Date 8 June 2006

Classes

Class 5 Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the Alzheimer's type, also known as Mild Cognitive Impairment, MCI, or prodromal Alzheimer's Disease, and mild, moderate, and severe dementia of the Alzheimer's type

Event Publications

4 January 2007 Application filed

25 January 2007 Application Accepted

24 May 2007 Trade Mark Registered/Protected

28 October 2010 Cancellation of Entrie in Register

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1151077-FRUGEL

1151075-INNOLATHE